Takatsuki, Japan

Yukihiro Kamiya

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Japan Tobacco Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yukihiro Kamiya. Retrieved from https://idiyas.com/inventor/yukihiro-kamiya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yukihiro Kamiya

Introduction

Yukihiro Kamiya is a notable inventor based in Takatsuki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of Janus kinase inhibitors. His work has implications for various therapeutic applications, showcasing his expertise and innovative spirit.

Latest Patents

Kamiya holds a patent for crystalline forms of a Janus kinase inhibitor. The patent details the compound 3-((3S,4R)-3-methyl-6-(7H-pyrrolo [2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl)-3-oxopropanenitrile (Compound A). This invention encompasses the crystalline forms, compositions, methods of preparation, methods of use, and methods of quantitation related to the compound. He has 1 patent to his name, reflecting his innovative contributions to the field.

Career Highlights

Yukihiro Kamiya is associated with Japan Tobacco Inc., where he continues to advance his research and development efforts. His work at the company has allowed him to explore new frontiers in medicinal chemistry and drug development.

Collaborations

Kamiya has collaborated with notable colleagues, including Noriaki Shimoyama and Ryuhei Okura. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Yukihiro Kamiya's contributions to the field of pharmaceuticals, particularly through his patent on Janus kinase inhibitors, highlight his role as an influential inventor. His work continues to impact the industry and pave the way for future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…